Common blood changes not independent predictor of adverse outcomes for kidney disease patients

Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European haemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that although haemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early...

Read the whole article on

More from